CIK 0001817229 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Vor Biopharma Inc.
Sign in to watch- Ticker
- VOR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 811591163
- Phone
- 617-655-6580
- Business address
- 500 BOYLSTON STREET, SUITE 1350, BOSTON, MA, 02116
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Open-market sale Director sold 221,166 shares at an average $28.06 ($6,204,863)
- 4 Open-market sale Director sold 117,050 shares at an average $29.34 ($3,433,992)
- 4 Open-market sale 10% owner sold 37,533 shares at an average $30.19 ($1,133,103)
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Open-market sale 10% owner sold 73,676 shares at an average $31.88 ($2,348,744)
- 4 Open-market sale Director sold 464,025 shares at an average $29.54 ($13,707,361)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Open-market sale 10% owner sold 96,657 shares at an average $31.08 ($3,003,706)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Open-market sale 10% owner sold 124,146 shares at an average $33.16 ($4,116,369)
Page 6 of 24 · 464 filings